We are looking for Colorado residents with

Parkinson’s disease to participate in Clinical Trials

There are several clinical trials for Parkinson’s Disease actively enrolling in Colorado to determine if investigational study drugs can relieve the symptoms associated with the condition.

Patients Who Might Qualify:
  • Are 30 years of age or older

  • Have a diagnosis of Parkinson’s disease

  • Take Parkinson’s medications to control symptoms

Why participate in research studies for Parkinson’s Disease?

We’re inviting Colorado patients to take part in a studies for individuals who are diagnosed with Parkinson’s Disease to evaluate the effect of investigational drugs on treating the symptoms associated with the condition. All study-related visits, tests, care, and study drug will be provided at no cost. In addition, compensation for study-related travel may be provided. Health insurance is not required to participate.

  • Overview: Clinical trials are done with human volunteers to add to medical knowledge to try and find new ways to treat, prevent, or detect diseases. They are a way to test if new investigational medications are safe and effective in treating the disease they are intended for. There are two types of clinical trials-interventional and observational.
  • Types of studies: Interventional studies are what people typically think of when thinking of research. Individuals are given a certain intervention (medication, surgery, etc.) to see if it is helpful. Observational studies gather important information about diseases and often look at cause and effect relationships. Patients in observational studies are not offered any new treatment options.

Volunteers who qualify to take part in studies may receive compensation for study-related travel. Please discuss this with the study team when they contact you.

There is no cost to participate in the Parkinson’s Disease Studies. If you qualify, all study-related visits, tests, care, and study drug will be provided at no cost.

If you decide to take part, you will receive study-related care throughout the study from a team of experienced doctors and nurses.

The research team will be able to explain more about what the Parkinson’s Disease Studies will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships or the care you receive.

Our research study clinic is located in the Denver metro area.

  • The idea for a clinical trial usually starts in a laboratory. Researchers first test their new product with animals to see if it does what they hope. They look to see if it is safe and helpful. Once this is done, the drug can be tested in humans to see if we get the same results
  • Sponsor: Every study is funded by an organization such as a pharmaceutical company, federally funded agencies (such as NIH), or an individual or organization. They are referred to as the sponsor of the study. The sponsor makes a lot of decisions about the study and chooses sites (or locations) that the study will be performed.
  • Site: There are many locations that the study can be performed. At each site, there is a principal investigator (PI), who is usually a doctor, and study coordinators that conduct the study. While you are in a study, you will generally see the same study coordinator and provider throughout the study. Most of the study tasks will be done with the study coordinator, and they should be your primary contact throughout the study.
  • Protocol: Each study has a written out plan of what everyone conducting the study needs to do; this is called the protocol. The protocol is written to protect the participants’ health and answer a particular research question. The medication and dosages are reviewed in the protocol as well as who is eligible for the study. The protocol also outlines what needs to be done at each visit and what time period they need to be done in.
  • IRB review: Studies are reviewed by an independent committee called the Institutional Review Board (IRB). The IRB reviews the protocol and study materials to confirm that, in their eyes, the risk is worth the potential benefit in the study. The primary goal of the IRB is to ensure the rights of the participants are maintained and the study is conducted ethically.
  • FDA: The Food and Drug Administration (FDA) also provides oversight to interventional studies to also ensure that volunteers’ rights and welfare are maintained and that the data is accurate. The FDA provides guidance on what should be done during a study. Once a study is completed, the sponsor can submit their data to the FDA to be reviewed. The FDA decides if there is enough evidence that the investigational medication is safe and effective to be approved and prescribed.
  • Time: Each clinical trial requires your time, but the requirement for each study is different. Before enrolling into a clinical trial, it is important to know how much time you will need to commit to the study.
  • You should personally weigh the risks and benefits involved in the study and make sure that you feel comfortable.
  • Each study has different risks associated and you should reference the Informed Consent Form for known potential side effects.
  • Since these are investigational treatments and medications there may be unknown side effects.
  • It is important to consider other treatment options available because while in the trial you maybe limited to other treatment options. However, if another treatment is clearly better at any time during the trial, your doctor will take you out of the trial to provide you with the best possible care.
  • Many clinical trials do not help the patients involved.
  • Routine Lab Work
  • Neurological Exams
  • More access to Physicians
  • Investigational medications
  • Caregiver and Patient reimbursement (study specific)
Learn more about Clinical Research